SPDR S&P Pharmaceuticals ETF (XPH) News Today $46.16 +0.16 (+0.35%) (As of 11/1/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatings All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Shuttle Pharmaceuticals prices $4.5M at-the-market offering at $1.525 per shareOctober 30 at 2:04 AM | markets.businessinsider.comBalanced Outlook on Apellis Pharmaceuticals: Promising Empaveli Data Amid Syfovre Growth ChallengesOctober 28, 2024 | markets.businessinsider.comBristol Myers Squibb: A High-Yield Bargain With Growth On The HorizonOctober 6, 2024 | seekingalpha.comBottom-up default shifts significantly lower for telecoms, pharma; higher for techAugust 30, 2024 | msn.comAstraZeneca Shares Fall Despite EPS Beat and Raised GuidanceAstraZeneca beat earnings-per-share (EPS) estimates and raised guidance, but shares still fell. Investors should watch for developments around the drug Enhertu.July 26, 2024 | marketbeat.comPharmaceutical Stocks - Best Pharmaceutical Stocks to Buy (XPH)Along with biotechnology and biotech companies, the pharma industry is a major part of the overall healthcare market. Pharmaceutical companies include some of the biggest stock gainers and some of the best growth stocks on the market. The pharmaceutical market has many amazing stocks to watch. The pharma industry may also be a good investment for those looking for dividend stocks since so many of the largest pharmaceutical companies pay a dividend to its shareholders. Though the industry has plenty of potential for growth, investors should also be aware that pharma stocks—especially smaller startups—can be risky. Investors buying pharma stocks should make sure to do their research and only invest in pharma stocks as part of a diversified portfolio.July 17, 2024 | marketbeat.comSPDR S&P Pharmaceuticals ETF (XPH)March 30, 2024 | finance.yahoo.comXPH: A More Balanced Way To Get Exposure To PharmaceuticalsMarch 28, 2024 | seekingalpha.comSPDR S&P Pharmaceuticals ETFFebruary 16, 2024 | wsj.comS&P 500 (SPX) today: Catalent Inc is a top mover, up 10%February 5, 2024 | usatoday.comSPDR S&P Pharmaceuticals ETF (ARCA:XPH), Quotes and News SummaryDecember 23, 2023 | benzinga.comSPDR S&P Pharmaceuticals ETF declares quarterly distribution of $0.1744December 18, 2023 | msn.comWhy the S&P 500 ETF’s rare triple ‘gap ups’ isn’t a buy signalNovember 6, 2023 | marketwatch.comXPH ETF Stock Price HistoryOctober 29, 2023 | investing.comETF Watch: Fortitude, Not Fashion Wins OutOctober 20, 2023 | thestreet.comSPDR Portfolio Mid Cap ETF declares quarterly distribution of $0.1758September 18, 2023 | msn.comHow Much Pain Will Lower Medicare Prices Cause for Pharma Stocks? (XPH)Pharmaceutical stocks are holding steady as Medicare price negotiations approach, but industry diversification and innovation support future growth prospects.September 1, 2023 | marketbeat.comWhat is behind big pharma's underperformance?June 25, 2023 | msn.comSPDR S&P Pharmaceuticals ETF declares quarterly distribution of $0.1235June 21, 2023 | msn.comSPY ETF Gains 11% YTD: Technical Indicators Signal Further UpsideMay 31, 2023 | markets.businessinsider.comWhen Spdr S&p Pharmaceuticals ($XPH) Moves Investors should ListenApril 12, 2023 | marketwatch.comXPH SPDR S&P Pharmaceuticals ETFMarch 22, 2023 | seekingalpha.comSPYV: How Microsoft And Amazon Changed The S&P 500 Value IndexJanuary 3, 2023 | seekingalpha.comEli Lilly: Right Industry, Wrong PriceDecember 27, 2022 | seekingalpha.comSPDR S&P Pharmaceuticals ETF declares quarterly distribution of $0.1940December 19, 2022 | msn.comSPDR S&P 500 ESG ETF declares quarterly distribution of $0.1728December 16, 2022 | msn.comXPH: U.S. Pharmaceuticals Stocks Are Probably Fairly Valued, Cyclically UnattractiveNovember 13, 2022 | seekingalpha.comChevron, Uber Technologies, And A Way To 'Bet Against The Big Guys' Are CNBC's 'Final Trades'November 2, 2022 | msn.comMDYG SPDR S&P 400 Mid Cap Growth ETFOctober 1, 2022 | seekingalpha.comSPDR S&P Pharmaceuticals ETF declares quarterly distribution of $0.1320September 21, 2022 | seekingalpha.comDrug ETFs Likely Winners of Health LawSeptember 7, 2022 | thestreet.comObamacare Still Sickly, After All These YearsSeptember 5, 2022 | thestreet.comSPDR S&P Pharmaceuticals ETF NewsJuly 2, 2022 | thestreet.comGordon Pape’s mailbag: Pharma ETFs, tax losses, undeclared capital gains and other investing questionsMay 24, 2022 | theglobeandmail.comIn a Sick Market, Can Pharmas Help?May 3, 2022 | realmoney.thestreet.com12.8% of XPH Holdings Seeing Recent Insider BuysApril 27, 2022 | nasdaq.comInsiders Buy the Holdings of XPH ETFMarch 18, 2022 | nasdaq.comViatris stands out amid selloff in generic drugmakersMarch 5, 2022 | seekingalpha.comIs SPDRSP PHARMA (XPH) a Strong ETF Right Now?November 15, 2021 | nasdaq.comThursday's ETF with Unusual Volume: XPHNovember 4, 2021 | nasdaq.com Get SPDR S&P Pharmaceuticals ETF News Delivered to You Automatically Sign up to receive the latest news and ratings for XPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Countdown to the biggest trade of my 25 yr career (Ad)Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… Breaking down the ONE MOVE you must make before the November 5th election to set yourself up for a prosperous 2025. Click here to see the surprising reason why XPH Media Mentions By Week XPH Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. XPH News Sentiment▼0.650.30▲Average News Sentiment XPH News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. XPH Articles This Week▼20▲XPH Articles Average Week Get SPDR S&P Pharmaceuticals ETF News Delivered to You Automatically Sign up to receive the latest news and ratings for XPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Simplify Health Care ETF News Today Invesco S&P SmallCap Health Care ETF News Today ALPS Medical Breakthroughs ETF News Today SPDR S&P Health Care Equipment ETF News Today ProShares Ultra Nasdaq Biotechnology News Today Invesco Biotechnology & Genome ETF News Today Invesco Nasdaq Biotechnology ETF News Today Langar Global HealthTech ETF News Today iShares U.S. Pharmaceuticals ETF News Today VanEck Pharmaceutical ETF News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSEARCA:XPH) was last updated on 11/2/2024 by MarketBeat.com Staff From Our PartnersMusk warns humanity: “Obsolete”The 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SPDR S&P Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share SPDR S&P Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
